Brief: Bioretec Has Been Granted FDA Breakthrough Device Designation Status For Its Remeos Drillpin
14/12/2025 15:46
Dec 14 (Reuters) - Bioretec Oy BRETEC.HE: INSIDE INFORMATION: BIORETEC HAS BEEN GRANTED FDA BREAKTHROUGH DEVICE DESIGNATION STATUS FOR ITS REMEOS™ DRILLPIN Source text: ID:nWkr18MlFk Further company coverage: BRETEC.HE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioretec Oy
See all newsBrief: Bioretec Initiates Change Negotiations
Brief: Bioretec Gets Marketing Authorization From FDA
Brief: Bioretec Receives FDA 510(K) Clearance For Its Activascrew Cannulated Com Bioabsorbable Compression Screw
Finland's Bioretec H1 revenue rises 12%, loss narrows
Brief: Bioretec Q2 Net Sales EUR 1.1 Million